|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.860 EUR | +0.77% |
|
-4.15% | +25.76% |
| Market Cap | 44.27M 50.97M 41.11M 37.91M 71.42M 4.87B 72.71M 487M 191M 2.42B 191M 187M 8.13B | P/E 2026 * |
-20.2x | P/E 2027 * | 197x |
|---|---|---|---|---|---|
| Enterprise Value | 42.77M 49.24M 39.72M 36.63M 69M 4.7B 70.25M 470M 184M 2.33B 185M 181M 7.85B | EV / Sales 2026 * |
3.89x | EV / Sales 2027 * | 2.71x |
| Free-Float |
29.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.77% | ||
| 1 week | -4.15% | ||
| Current month | +1.29% | ||
| 1 month | +1.29% | ||
| 3 months | +6.22% | ||
| 6 months | +12.29% | ||
| Current year | +25.76% |
| 1 week | 7.3 | 8.3 | |
| 1 month | 7.3 | 8.94 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.5 | 9.1 | |
| 3 years | 2.14 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.77% | -4.15% | +3.42% | +211.90% | 50M | ||
| -4.55% | -2.61% | +51.95% | +151.91% | 1,079B | ||
| -3.66% | -1.33% | +52.95% | +46.62% | 640B | ||
| -2.24% | +0.19% | +35.97% | +70.64% | 465B | ||
| -2.29% | +1.12% | +36.13% | +31.18% | 353B | ||
| -2.28% | -0.69% | +33.42% | +40.48% | 301B | ||
| -3.15% | +0.25% | +10.63% | +15.03% | 271B | ||
| -2.12% | +3.31% | +1.82% | -37.38% | 228B | ||
| 0.00% | +4.34% | +28.63% | +64.00% | 209B | ||
| -1.09% | +0.32% | +14.40% | +70.80% | 165B | ||
| Average | -1.57% | +4.35% | +26.93% | +66.52% | 370.97B | |
| Weighted average by Cap. | -1.62% | +4.86% | +38.04% | +72.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11M 12.66M 10.21M 9.42M 17.75M 1.21B 18.07M 121M 47.35M 600M 47.56M 46.52M 2.02B | 16M 18.42M 14.86M 13.7M 25.81M 1.76B 26.28M 176M 68.87M 873M 69.17M 67.66M 2.94B |
| Net income | -2.25M -2.59M -2.09M -1.93M -3.63M -247M -3.7M -24.74M -9.69M -123M -9.73M -9.51M -413M | 250K 288K 232K 214K 403K 27.48M 411K 2.75M 1.08M 13.65M 1.08M 1.06M 45.89M |
| Net Debt | -1.5M -1.73M -1.39M -1.28M -2.42M -165M -2.46M -16.49M -6.46M -81.88M -6.49M -6.34M -275M | -900K -1.04M -836K -771K -1.45M -98.92M -1.48M -9.89M -3.87M -49.13M -3.89M -3.81M -165M |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | EUR 7.860 | +0.77% | 514 |
| 29/07/26 | EUR 7.800 | -2.50% | 2,563 |
| 28/07/26 | EUR 8.000 | -1.23% | 295 |
| 27/07/26 | EUR 8.100 | -2.41% | 147 |
| 24/07/26 | EUR 8.300 | +1.22% | 312 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.860EUR
Average target price
8.200EUR
Spread / Average Target
+4.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















